Literature DB >> 14972510

Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.

Pinhas Degtyar1, Endre Neulander, Howard Zirkin, Igor Yusim, Amos Douvdevani, Wilmosh Mermershtain, Jacob Kaneti, Ester Manor.   

Abstract

OBJECTIVES: To evaluate comparatively fluorescence in situ hybridization (FISH) and cytology performed on exfoliated urothelial cells obtained from voided urine and bladder washings as a method of diagnosis and follow-up in patients with transitional cell carcinoma (TCC) of the bladder.
METHODS: Thirty patients with confirmed bladder TCC, 10 patients enrolled in cystoscopy follow-up for previous bladder tumors, and 10 patients with bladders free of tumor without a previous history of bladder TCC underwent cytologic examination and FISH performed on voided urine and bladder washing specimens. The FISH probes were targeted to chromosomes 7 and 9.
RESULTS: FISH had a sensitivity of 92% for high-grade tumors in both voided urine and bladder washing specimens, significantly greater than that of cytology at a sensitivity of 64% in voided urine and 67% in the bladder washing specimens (P = 0.02). The sensitivity of FISH and cytology were both low and not significantly different statistically from each other for the low-grade tumors. Monosomy of chromosome 9 correlated with early tumor recurrence. Polysomy of chromosomes 7 and 9 correlated with high-grade tumors (80% and 92%, respectively).
CONCLUSIONS: According to our results, with the local cytopathology expertise, FISH performed on urothelial cells from voided urine has a sensitivity that supersedes that of cytology, making the former a valuable complementary method in the diagnosis and follow-up of patients with bladder TCC.

Entities:  

Mesh:

Year:  2004        PMID: 14972510     DOI: 10.1016/j.urology.2003.08.026

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  The value of the preoperative FISH test in unscreened bladder cancer patients with TUR indications.

Authors:  S V Petrov; K A Malkhasyan; M Yu Ulyanin; E F Abdrakhmanov; R Sh Khasanov
Journal:  Pathol Oncol Res       Date:  2012-06-23       Impact factor: 3.201

Review 2.  Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer.

Authors:  Matthew E Nielsen; Mark L Gonzalgo; Mark P Schoenberg; Robert H Getzenberg
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 3.  Management of High-grade T1 Urothelial Carcinoma.

Authors:  Peter A Reisz; Aaron A Laviana; Sam S Chang
Journal:  Curr Urol Rep       Date:  2018-10-26       Impact factor: 3.092

4.  Virtual cystoscopy (pneumo-cystoscopy)-Its utility in the prospective evaluation of bladder tumor.

Authors:  Iqbal Singh; Gopesh Mehrotra; Maninder S Jaura; Vivek Agarwal; Anupama Tandon; Mohit Joshi
Journal:  Indian J Urol       Date:  2012-04

5.  Basics of cytology.

Authors:  Mousa A Al-Abbadi
Journal:  Avicenna J Med       Date:  2011-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.